We modeled three pricing scenarios based on CMS negotiated rates and anticipated generic competition: Low scenario (generic semaglutide becomes available): $2,940 per year Mid scenario (blended Wegovy, Mounjaro, Zepbound): $3,600 per year High scenario (newest brands before generics): $4,200 per year The mid scenario projects the following: Years 1-2 (2027-2028): Ramp-up phase
With more than 60 years of experience, Weight Watchers is the most studied commercial weight management program in the world, delivered through its No
Furthermore, taking in significantly fewer calories while on GLP-1s results in not just fat loss, but also weight loss from breakdown of lean muscle to sustain your bodys energy needs
Just like with a diet, it takes everyday action over time to see a difference
This process reflects the same care and attention to detail that you are applying to your metabolic health
GLP-1 therapy doesnt affect ability to handle service or K-9 animals